Braiin
- Market cap
- 885.87M
- P/E (TTM)i
- -30.70
- P/Bi
- 3.95
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 0%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 2.84% +0.02pp
- Institutions
- 12 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-03-18
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
8 filings tracked · 0 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Natraj Balasubramanian | Chief Executive Officer | 59.52% |
| Chetan Saligrama | President | 6.74% |
| James Stephenson | Chief Financial Officer | 0.31% |
| Rohit Jhamb | Chief Business Officer | 0.09% |
| Ragur Padmanabhan | Independent Director | 0.08% |
| Usha Murphy | Independent Director | 0.05% |
| Stephen Buehler | Independent Director | -- |
| Samir Pandey | Chief Strategy Officer | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-03-17 | James Stephenson | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Stephen Buehler | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Samir Pandey | Chief Strategy Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Natraj Balasubramanian | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Chetan Saligrama | President | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Ragur Padmanabhan | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Usha Murphy | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Rohit Jhamb | Chief Business Officer | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:39:14 · For reference only, not investment advice and not tailored to your situation.